Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.

The Journal of clinical endocrinology and metabolism - 1 Sept 2015

Falhammar Henrik, Frisén Louise, Hirschberg Angelica Linden, Norrby Christina, Almqvist Catarina, Nordenskjöld Agneta, Nordenström Anna

Abstract excerpt

CONTEXT: Congenital adrenal hyperplasia (CAH) is lethal in its most severe forms if not treated with glucocorticoids. However, glucocorticoids may increase the risk of cardiovascular and metabolic morbidity. OBJECTIVE: This study aimed to study cardiovascular and metabolic morbidity in CAH. DESIGN, SETTING, AND PARTICIPANTS: Patients with CAH due to 21-hydroxylase deficiency (n = 588; >80% with known CYP21A2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Hyperplasia, Congenital
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant, Newborn

Share to Metabolic Diseases

Share to Neonatal Screening

Share to Prevalence

Share to Steroid 21-Hydroxylase

Source

Identifiers

PMID: 26126207
DOI: 10.1210/JC.2015-2093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.PMID 26126207Read ↗

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Semantic proximity Read ↗

Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Semantic proximity Read ↗

Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.Semantic proximity Read ↗

Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study.Semantic proximity Read ↗

Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Semantic proximity Read ↗

Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood.Semantic proximity Read ↗

[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].Semantic proximity Read ↗

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.Semantic proximity Read ↗

Congenital adrenal hyperplasia in Saudi Arabia: Epidemiology, genetic mutations, and evolving management strategies.Semantic proximity Read ↗

Genotype and clinical outcomes in children with congenital adrenal hyperplasia.Semantic proximity Read ↗

Congenital Adrenal Hyperplasia Case Attending With Hypertension Diagnosed With 21OH DeficiencySemantic proximity Read ↗

Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.